Re F - Search Results

1

Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity.

Re F, Giorgetti S, Biondi B, Scapin S, Mantegazza F, Cassina V, Sesana SM, Rizzi L, Eberini I, Palazzolo L, Beeg M, Gobbi M, Sardina M, Masserini M. Re F, et al. Ann Med. 2023 Dec;55(1):2205659. doi: 10.1080/07853890.2023.2205659. Ann Med. 2023. PMID: 37143345 Free PMC article.

2

Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons.

Cazzaniga E, Bulbarelli A, Cassetti A, Lonati E, Re F, Palestini P, Mutoh T, Masserini M. Cazzaniga E, et al. Among authors: re f. J Neurosci Res. 2007 Aug 1;85(10):2253-61. doi: 10.1002/jnr.21354. J Neurosci Res. 2007. PMID: 17510978

3

Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system.

Re F, Sesana S, Barbiroli A, Bonomi F, Cazzaniga E, Lonati E, Bulbarelli A, Masserini M. Re F, et al. FEBS Lett. 2008 Jan 23;582(2):215-20. doi: 10.1016/j.febslet.2007.12.003. Epub 2007 Dec 17. FEBS Lett. 2008. PMID: 18082145 Free article.

4

Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes.

Sesana S, Re F, Bulbarelli A, Salerno D, Cazzaniga E, Masserini M. Sesana S, et al. Among authors: re f. Biochemistry. 2008 May 13;47(19):5433-40. doi: 10.1021/bi800005s. Epub 2008 Apr 17. Biochemistry. 2008. PMID: 18416535

5

TrkA pathway activation induced by amyloid-beta (Abeta).

Bulbarelli A, Lonati E, Cazzaniga E, Re F, Sesana S, Barisani D, Sancini G, Mutoh T, Masserini M. Bulbarelli A, et al. Among authors: re f. Mol Cell Neurosci. 2009 Mar;40(3):365-73. doi: 10.1016/j.mcn.2008.12.006. Epub 2008 Dec 25. Mol Cell Neurosci. 2009. PMID: 19162192

6

Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.

Gobbi M, Re F, Canovi M, Beeg M, Gregori M, Sesana S, Sonnino S, Brogioli D, Musicanti C, Gasco P, Salmona M, Masserini ME. Gobbi M, et al. Among authors: re f. Biomaterials. 2010 Sep;31(25):6519-29. doi: 10.1016/j.biomaterials.2010.04.044. Biomaterials. 2010. PMID: 20553982

7

Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer's disease.

Re F, Airoldi C, Zona C, Masserini M, La Ferla B, Quattrocchi N, Nicotra F. Re F, et al. Curr Med Chem. 2010;17(27):2990-3006. doi: 10.2174/092986710791959729. Curr Med Chem. 2010. PMID: 20629631 Review.

8

Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells.

Cazzaniga E, Bulbarelli A, Lonati E, Orlando A, Re F, Gregori M, Masserini M. Cazzaniga E, et al. Among authors: re f. Neurochem Res. 2011 May;36(5):863-9. doi: 10.1007/s11064-011-0415-4. Epub 2011 Feb 3. Neurochem Res. 2011. PMID: 21287268

9

The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue.

Canovi M, Markoutsa E, Lazar AN, Pampalakis G, Clemente C, Re F, Sesana S, Masserini M, Salmona M, Duyckaerts C, Flores O, Gobbi M, Antimisiaris SG. Canovi M, et al. Among authors: re f. Biomaterials. 2011 Aug;32(23):5489-97. doi: 10.1016/j.biomaterials.2011.04.020. Epub 2011 May 6. Biomaterials. 2011. PMID: 21529932

10

Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.

Re F, Cambianica I, Zona C, Sesana S, Gregori M, Rigolio R, La Ferla B, Nicotra F, Forloni G, Cagnotto A, Salmona M, Masserini M, Sancini G. Re F, et al. Nanomedicine. 2011 Oct;7(5):551-9. doi: 10.1016/j.nano.2011.05.004. Epub 2011 May 20. Nanomedicine. 2011. PMID: 21658472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

463 results

Search Page